Oxytocin versus carbetocine to prevent post partum hemorrhage following cesarean section

Descripción del Articulo

Background: Postpartum haemorrhage (PPH) is the single most important cause of maternal mortality, and uterine atony is its most common cause. The best treatment is prevention. Oxytocin reduces the risk of PPH. In Spain carbetocin has been marketed, a human oxytocin analogue that has rapid onset of...

Descripción completa

Detalles Bibliográficos
Autores: Navarro Díaz, Begoña, Castro Samper, Noelia, Córdoba Medina, Nerea, Fernández Díaz, Laura, Millà Jover, Alfredo, Rodríguez Ingelmo, José María
Formato: artículo
Fecha de Publicación:2014
Institución:Sociedad Peruana de Obstetricia y Ginecología
Repositorio:Revista Peruana de Ginecología y Obstetricia
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/110
Enlace del recurso:http://51.222.106.123/index.php/RPGO/article/view/110
Nivel de acceso:acceso abierto
id REVSPOG_e45863ad4e0a95c5508111fdb2145dd7
oai_identifier_str oai:ojs.pkp.sfu.ca:article/110
network_acronym_str REVSPOG
network_name_str Revista Peruana de Ginecología y Obstetricia
repository_id_str .
dc.title.none.fl_str_mv Oxytocin versus carbetocine to prevent post partum hemorrhage following cesarean section
Oxitocina frente a carbetocina para prevenir hemorragias posparto tras cesárea
title Oxytocin versus carbetocine to prevent post partum hemorrhage following cesarean section
spellingShingle Oxytocin versus carbetocine to prevent post partum hemorrhage following cesarean section
Navarro Díaz, Begoña
title_short Oxytocin versus carbetocine to prevent post partum hemorrhage following cesarean section
title_full Oxytocin versus carbetocine to prevent post partum hemorrhage following cesarean section
title_fullStr Oxytocin versus carbetocine to prevent post partum hemorrhage following cesarean section
title_full_unstemmed Oxytocin versus carbetocine to prevent post partum hemorrhage following cesarean section
title_sort Oxytocin versus carbetocine to prevent post partum hemorrhage following cesarean section
dc.creator.none.fl_str_mv Navarro Díaz, Begoña
Castro Samper, Noelia
Córdoba Medina, Nerea
Fernández Díaz, Laura
Millà Jover, Alfredo
Rodríguez Ingelmo, José María
author Navarro Díaz, Begoña
author_facet Navarro Díaz, Begoña
Castro Samper, Noelia
Córdoba Medina, Nerea
Fernández Díaz, Laura
Millà Jover, Alfredo
Rodríguez Ingelmo, José María
author_role author
author2 Castro Samper, Noelia
Córdoba Medina, Nerea
Fernández Díaz, Laura
Millà Jover, Alfredo
Rodríguez Ingelmo, José María
author2_role author
author
author
author
author
description Background: Postpartum haemorrhage (PPH) is the single most important cause of maternal mortality, and uterine atony is its most common cause. The best treatment is prevention. Oxytocin reduces the risk of PPH. In Spain carbetocin has been marketed, a human oxytocin analogue that has rapid onset of action and an average life 4-10 times longer than oxytocin, producing tonic contraction that reduces postpartum blood loss. Objectives: To compare effects of carbetocin and oxytocin, in order to prevent postpartum haemorrhage after cesarean section. Design: Observational retrospective comparative study. Setting: Obstetrics and Gynecology Service, Hospital General Universitario de Elche, Alicante, España. Participants: Pregnant women with risk factor of uterine atony following cesarean section. Methods: From April 2010 through March 2012 247 women with a risk factor for uterine atony after cesarean section The effects of administering 100 micrograms of carbetocin and 10 UI of oxytocin following delivery were compared. Hemoglobin levels prior and 24-48 hours after cesarean section and the percentage of transfusions given were assessed. Main outcome measures: Anemia, blood transfusions, intravenous iron. Results: In the group of carbetocin, hemoglobin decreased less than in the oxytocin group (P=0.56), and there was less anaemia after cesarean section (P=0,852). Transfusions and intravenous iron did not provide conclusive data. Conclusions: There were no significant differences between carbetocin and oxytocin to prevent PPH after cesarean sections.
publishDate 2014
dc.date.none.fl_str_mv 2014-05-21
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://51.222.106.123/index.php/RPGO/article/view/110
url http://51.222.106.123/index.php/RPGO/article/view/110
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv http://51.222.106.123/index.php/RPGO/article/view/110/100
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
dc.source.none.fl_str_mv The Peruvian Journal of Gynecology and Obstetrics ; Vol. 60 No. 1 (2014); 53-58
Revista Peruana de Ginecología y Obstetricia; Vol. 60 Núm. 1 (2014); 53-58
2304-5132
2304-5124
reponame:Revista Peruana de Ginecología y Obstetricia
instname:Sociedad Peruana de Obstetricia y Ginecología
instacron:SPOG
instname_str Sociedad Peruana de Obstetricia y Ginecología
instacron_str SPOG
institution SPOG
reponame_str Revista Peruana de Ginecología y Obstetricia
collection Revista Peruana de Ginecología y Obstetricia
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1845882445991247872
spelling Oxytocin versus carbetocine to prevent post partum hemorrhage following cesarean sectionOxitocina frente a carbetocina para prevenir hemorragias posparto tras cesáreaNavarro Díaz, BegoñaCastro Samper, NoeliaCórdoba Medina, NereaFernández Díaz, LauraMillà Jover, AlfredoRodríguez Ingelmo, José MaríaBackground: Postpartum haemorrhage (PPH) is the single most important cause of maternal mortality, and uterine atony is its most common cause. The best treatment is prevention. Oxytocin reduces the risk of PPH. In Spain carbetocin has been marketed, a human oxytocin analogue that has rapid onset of action and an average life 4-10 times longer than oxytocin, producing tonic contraction that reduces postpartum blood loss. Objectives: To compare effects of carbetocin and oxytocin, in order to prevent postpartum haemorrhage after cesarean section. Design: Observational retrospective comparative study. Setting: Obstetrics and Gynecology Service, Hospital General Universitario de Elche, Alicante, España. Participants: Pregnant women with risk factor of uterine atony following cesarean section. Methods: From April 2010 through March 2012 247 women with a risk factor for uterine atony after cesarean section The effects of administering 100 micrograms of carbetocin and 10 UI of oxytocin following delivery were compared. Hemoglobin levels prior and 24-48 hours after cesarean section and the percentage of transfusions given were assessed. Main outcome measures: Anemia, blood transfusions, intravenous iron. Results: In the group of carbetocin, hemoglobin decreased less than in the oxytocin group (P=0.56), and there was less anaemia after cesarean section (P=0,852). Transfusions and intravenous iron did not provide conclusive data. Conclusions: There were no significant differences between carbetocin and oxytocin to prevent PPH after cesarean sections.Antecedentes: La hemorragia posparto (HPP) es la causa aislada más importante de mortalidad materna y su causa más frecuente es la atonía uterina. El mejor tratamiento es su prevención. La oxitocina reduce el riesgo de HPP. Se ha comercializado en España la carbetocina, análogo de la oxitocina humana que tiene inicio de acción rápido y una vida media 4 a 10 veces más larga que la oxitocina, produciendo una contracción tónica que reduce la pérdida hemática posparto. Objetivos: Comparar efectos de carbetocina y oxitocina para prevenir hemorragias posparto tras cesárea. Diseño: Estudio observacional retrospective de comparación. Institución: Servicio de Obstetricia y Ginecología, Hospital General Universitario de Elche, Alicante, España. Participantes: Gestantes con factor de riesgo de atonía uterina tras cesárea. Metodología: Se ha incluido 247 mujeres con algún factor de riesgo de atonía uterina tras cesárea, estudiadas desde abril de 2010 hasta marzo de 2012. Se ha comparado los efectos de administrar 100 microgramos de carbetocina y 10 UI de oxitocina tras el alumbramiento. Se ha evaluado las cifras de hemoglobina previas a la cesárea y tras 24 a 48 horas de la misma, y el porcentaje de transfusiones realizadas. Principales medidas de resultados: Anemia, transfusiones sanguíneas, hierro intravenoso. Resultados: En el grupo carbetocina, la hemoglobina tras la cesárea descendió menos (P=0,56) y existió menos casos de anemia tras la misma (P=0,852). Las transfusiones y el hierro intravenoso no aportaron datos concluyentes. Conclusiones: No existieron diferencias estadísticamente significativas entre carbetocina y oxitocina para prevenir HPP tras cesáreas.Sociedad Peruana de Obstetricia y Ginecología2014-05-21info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://51.222.106.123/index.php/RPGO/article/view/110The Peruvian Journal of Gynecology and Obstetrics ; Vol. 60 No. 1 (2014); 53-58Revista Peruana de Ginecología y Obstetricia; Vol. 60 Núm. 1 (2014); 53-582304-51322304-5124reponame:Revista Peruana de Ginecología y Obstetriciainstname:Sociedad Peruana de Obstetricia y Ginecologíainstacron:SPOGspahttp://51.222.106.123/index.php/RPGO/article/view/110/100info:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/1102014-05-21T09:23:42Z
score 13.361153
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).